News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LaBrosse Nicole
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/21/2023 |
4
| LaBrosse Nicole (SVP, CFO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 2,525 shares
@ $49.26, valued at
$124.4k
Exercised 5,094 restricted stock units
@ $0
Granted 61,061 options to buy
@ $49.26, valued at
$3M
Granted 21,316 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| LaBrosse Nicole (SVP, CFO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,392 shares
@ $48.92, valued at
$68.1k
Paid exercise price by delivering 681 shares
@ $48.92, valued at
$33.3k
Exercised 2,503 restricted stock units
@ $0
Exercised 1,389 restricted stock units
@ $0 |
|
| 11/16/2022 |
4
| LaBrosse Nicole (SVP, CFO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 4,635 shares
@ $53.82, valued at
$249.5k
Sold 365 shares
@ $53.69, valued at
$19.6k
|
|
| 02/17/2022 |
4
| LaBrosse Nicole (SVP, CFO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 433 shares
@ $34.43, valued at
$14.9k
Exercised 1,255 restricted stock units
@ $0
Granted 62,315 options to buy
@ $34.36, valued at
$2.1M
Granted 20,373 restricted stock units
@ $0 |
|
| 02/14/2022 |
4
| LaBrosse Nicole (SVP, CFO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,025 shares
@ $34.94, valued at
$35.8k
Paid exercise price by delivering 506 shares
@ $34.2, valued at
$17.3k
Paid exercise price by delivering 427 shares
@ $33.64, valued at
$14.4k
Exercised 2,503 restricted stock units
@ $0
Exercised 1,389 restricted stock units
@ $0
Exercised 1,256 restricted stock units
@ $0 |
|
| 02/11/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|